Purpose To increase awareness, outline strategies, and offer guidance on the recommended
management of immune-related adverse events in patients treated with immune …

PURPOSE Non–small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR)
exon 20 insertion (Exon20ins) mutations exhibits inherent resistance to approved …

Purpose To update the 2006 American Society of Clinical Oncology guideline on the use of
hematopoietic colony-stimulating factors (CSFs). Methods The American Society of Clinical …

PURPOSE Pembrolizumab monotherapy has demonstrated durable antitumor activity in
advanced programmed death ligand 1 (PD-L1)–expressing non‒small-cell lung cancer (…

Purpose Provide evidence-based recommendations updating the 2015 ASCO guideline on
systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC). Methods …

Purpose Most crizotinib-treated patients with anaplastic lymphoma kinase gene (ALK)–rearranged
non–small-cell lung cancer (ALK-positive NSCLC) eventually experience disease …

Purpose: Complete and timely tissue genotyping is challenging, leading to significant numbers
of patients with newly diagnosed metastatic non–small cell lung cancer (mNSCLC) being …

Purpose In response to advances in the field, the College of American Pathologists (CAP),
the International Association for the Study of Lung Cancer (IASLC), and the Association for …

PURPOSE To provide evidence-based recommendations updating the 2017 ASCO guideline
on systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC) with …

… Leighl, Ronald Feld, Thomas Cerny, and Frances A. Shepherd A B S T R A C T … Mok TS,
Zee B, Nguyen B, et al: A prospective randomized study comparing toxicity and quality of life …